Top Companies in Cell Culture

The cell culture market is projected to reach USD 50.69 billion by 2030 from an estimated USD 29.76 billion in 2025, at a CAGR of 11.2% during the forecast period. The major factors driving the growth of this cell culture market include growing government support and funding for cell-based research, rising adoption of single-use technologies, and increasing incidences of infectious diseases.

Emerging cell culture technologies for the production of cell-based viral vaccines also contribute to market growth. Furthermore, the growing popularity of monoclonal antibodies and biosimilars, alongside the increasing focus of key players on product launches, is expected to create further growth opportunities for the market in the coming years.

To know about the assumptions considered for the study download the pdf brochure

The global cell culture market is consolidated with top players contributing to the major share, including Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), and Corning Incorporated (US). The market players have adopted various strategies such as new product launches, acquisitions, agreements, collaborations, and geographical expansions to strengthen their position in the global cell culture market.

• In March 2025, Thermo Fisher Scientific Inc. launched new lines of floor-model centrifuges (Thermo Scientific Cryofuge, Thermo Scientific BIOS, and Thermo Scientific LYNX centrifuges) that feature natural refrigerant cooling systems. In June 2024, Merck KGaA invested ~USD 200 million (Euros 180 million) to expand its Life Science distribution center in Schnelldorf, Germany.

Thermo Fisher Scientific Inc. (US):

Thermo Fisher Scientific is a leading provider of scientific solutions, offering a diverse range of products in the cell culture market, including cell culture media, reagents, supplements, and advanced technologies for cell growth and maintenance, enabling researchers to achieve optimal results in their experiments and bioproduction processes. Its leading position is attributed to its strong brand image and robust product portfolio. The company offers its products through well-established brands such as Gibco, Nunc, Countess, Dynabeads, and HyPerforma. It has focused on product launches, expansions, and acquisitions in the last three years. In April 2025, Thermo Fisher Scientific Inc. launched the 5L DynaDrive Single-Use Bioreactor to simplify and accelerate process development.

Danaher (US):

Danaher is a leading life sciences and diagnostics innovator providing a wide range of products and services for medical, industrial, and commercial applications. With this strong global presence, Danaher Corporation is constantly involved in acquisitions and partnerships. For instance, in October 2022, Cytiva acquired CEVEC Pharmaceuticals. This acquisition strengthened Cytiva’'s position in biomanufacturing solutions and allows its customers to have immediate access to technologies. Additionally, the company emphasizes expanding its capabilities in the cell culture market. In September 2023, Cytiva expanded its facility with the establishment of a new Center of Excellence for single-use technologies in Shanghai. This facility is designed to help advance and accelerate the development of novel therapeutics.

Meck KGaA (Germany):

Merck KGaA offers a wide range of cell culture products, including media, sera, supplements, and reagents, catering to various research, bioprocessing, and clinical applications. They are widely used in biopharmaceutical manufacturing. The company has a strong international presence, with a wide distribution network and established relationships with research institutions, and biotechnology & pharmaceutical companies worldwide. Merck focuses on expanding its presence in emerging markets due to the growing demand for cell culture products. This involves establishing partnerships, distribution networks, and manufacturing facilities in regions such as Asia Pacific and Latin America. In July 2024, Merck invested around USD 7.1 million (EUR 6.6 million) to expand commercial production of its first GMP-compliant manufacturing line for cell culture media (CCM) in China.

Market Ranking:

The cell culture market is consolidated, with five main players collectively holding 60–70% of the total market share. Thermo Fisher Scientific Inc. leads with its expansive portfolio of sera, media, and cultureware, supported by a strong global distribution network. Merck KGaA leverages organic and inorganic growth strategies, including product launches, expansions, acquisitions, and collaborations, to expand its media and bioprocessing capabilities. Sartorius has rapidly gained ground through its robust bioreactor systems and media solutions, and its focus is on automation and single-use technologies. Danaher, through Cytiva and Pall, strengthens its position with continuous investments in cell culture innovation and biomanufacturing infrastructure. Corning specializes in high-quality cell culture vessels and advanced surface treatments, with a growing focus on 3D cell culture and cell therapy applications.

The remaining 30–40% of the market is shared among other players. Market competition is driven by various factors, including product launches, cost-effectiveness, regulatory compliance, innovation in products, and the growing demand for personalized medicine and drug discovery.

Related Reports:

Cell Culture Market by Product (Consumables (Media, Sera, Reagent, Vessels (Roller bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), End User - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com